<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7076747/results/search/disease/results.xml">
  <result pre="courier ; font-style : italic;} Clin Infect DisClin. Infect. DiscidClinical" exact="Infectious" post="Diseases: An Official Publication of the Infectious Diseases Society"/>
  <result pre="DisClin. Infect. DiscidClinical Infectious Diseases: An Official Publication of the" exact="Infectious" post="Diseases Society of America1058-48381537-6591Oxford University PressUS pmcid: 7076747 doi:"/>
  <result pre="Infect. DiscidClinical Infectious Diseases: An Official Publication of the Infectious" exact="Diseases" post="Society of America1058-48381537-6591Oxford University PressUS pmcid: 7076747 doi: 10.1093/cid/ciz370ciz370"/>
  <result pre="or Boost: That Is the Question ArendSandra M1JedemaInge2[1], Department of" exact="Infectious" post="Diseases, Leiden University Medical CenterThe Netherlands[2], Department of Hematology,"/>
  <result pre="University Medical CenterThe Netherlands Correspondence: S. M. Arend, Department of" exact="Infectious" post="Diseases, C5-P-40, Leiden University Medical Center, PO Box 9600,"/>
  <result pre="cell transplantation (HSCT), with the associated high risk of graft-vs-host" exact="disease" post="(GVHD), CMV remains a significant cause of morbidity and"/>
  <result pre="the part of the recipients. In this issue of Clinical" exact="Infectious" post="Diseases, Zhao and colleagues report on a clinical phase"/>
  <result pre="safe and lowered the risk of late or persistent CMV" exact="infection" post="compared to a high-risk control group. However, CMV infection"/>
  <result pre="CMV infection compared to a high-risk control group. However, CMV" exact="infection" post="in the setting of stem cell transplantation is a"/>
  <result pre="serostatus is an important determinant of the risk of CMV" exact="infection" post="after allogeneic HSCT. Leaving apart D–/R– recipients, the risk"/>
  <result pre="D–/R+ transplantations [7]. The study by Zhao et al was" exact="limited" post="to concordant seropositive donor/recipient pairs, thus a high-risk group."/>
  <result pre="donor-derived ATC, although they have the highest risk of CMV" exact="infection" post="and disease [8]. The risk is high because the"/>
  <result pre="although they have the highest risk of CMV infection and" exact="disease" post="[8]. The risk is high because the graft only"/>
  <result pre="are actually (CD34+) progenitor cells; the remainder consist of the" exact="peripheral" post="blood repertoire of mononuclear cells, of which roughly half"/>
  <result pre="failure of ATC in certain donor/recipient pairs. GRAFT-VERSUS-HOST DISEASE CMV" exact="infection" post="and GVHD are intricately related [11]. In all previous"/>
  <result pre="lost reproductive potential. However, the main study result was a" exact="lower" post="rate of late and persistent CMV. Based on data"/>
  <result pre="Rev2014; 258:12–29.24517423 3.MaffiniE, GiacconeL, FestucciaM, BrunelloL, BuscaA, BrunoBTreatment of CMV" exact="infection" post="after allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol2016;"/>
  <result pre="hematopoietic stem cell transplantation. Expert Rev Hematol2016; 9:585–96.27043241 4.PandeA, DubberkeERCytomegalovirus" exact="infections" post="of the stem cell transplant recipient and hematologic malignancy"/>
  <result pre="cell transplantation: a review on CMV-specific T cell reconstitution. Biol" exact="Blood" post="Marrow Transplant2018; 24:1776–82.29626514 6.ZhaoXY, PeiXY, ChangYJ, et al.First-line therapy"/>
  <result pre="al.First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV" exact="infection" post="by promoting antiviral immunity after allogenic stem cell transplantation."/>
  <result pre="cell transplantation. Clin Infect Dis2020; 70:1429–37. 7.CamargoJF, KomanduriKVEmerging concepts in" exact="cytomegalovirus infection" post="following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell"/>
  <result pre="transplantation. Clin Infect Dis2020; 70:1429–37. 7.CamargoJF, KomanduriKVEmerging concepts in cytomegalovirus" exact="infection" post="following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell"/>
  <result pre="et al.CMV seronegative donors: effect on clinical severity of CMV" exact="infection" post="and reconstitution of CMV-specific immunity. Transpl Immunol2018; 49:54–8.29679650 9.HanleyPJ,"/>
  <result pre="et al.CMV-specific T cells generated from naive T cells recognize" exact="atypical" post="epitopes and may be protective in vivo. Sci Transl"/>
  <result pre="et al.Evidence for a bidirectional relationship between cytomegalovirus replication and" exact="acute" post="graft-versus-host disease. Biol Blood Marrow Transplant2010; 16:1309–14.20353832 12.MengerL, GoubleA,"/>
  <result pre="bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol" exact="Blood" post="Marrow Transplant2010; 16:1309–14.20353832 12.MengerL, GoubleA, MarzoliniMA, et al.TALEN-mediated genetic"/>
  <result pre="of cytomegalovirus (CMV)-specific T cells for the treatment of CMV" exact="infection" post="not responding to antiviral chemotherapy. Blood2002; 99:3916–22.12010789 15.FeuchtingerT, OpherkK,"/>
  <result pre="of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus" exact="disease" post="or reactivation after haploidentical and matched unrelated stem cell"/>
  <result pre="49:1851–60.19911966 18.PeggsKS, VerfuerthS, PizzeyA, et al.Adoptive cellular therapy for early" exact="cytomegalovirus infection" post="after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet2003;"/>
  <result pre="18.PeggsKS, VerfuerthS, PizzeyA, et al.Adoptive cellular therapy for early cytomegalovirus" exact="infection" post="after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet2003;"/>
  <result pre="T cells. J Clin Invest2005; 115:1616–26.15931392 20.RoddieC, PeggsKSImmunotherapy for transplantation-associated" exact="viral" post="infections. J Clin Invest2017; 127:2513–22.28628043 21.MartyFM, LjungmanP, ChemalyRF, et"/>
 </snippets>
</snippetsTree>
